Diagnostic, therapeutic, and prognostic implications of the 2021 World Health Organization classification of tumors of the central nervous system

S Gritsch, TT Batchelor, LN Gonzalez Castro - Cancer, 2022 - Wiley Online Library
The 2016 revised fourth edition of the World Health Organization (WHO) classification of
central nervous system (CNS) tumors incorporated molecular features with histologic …

Emerging systemic treatment options in meningioma

MJ Mair, AS Berghoff, PK Brastianos… - Journal of Neuro …, 2023 - Springer
Purpose Meningiomas are the most frequently diagnosed intracranial neoplasms. Usually,
they are treated by surgical resection in curative intent. Radiotherapy and stereotactic …

[HTML][HTML] Recent advances in organotypic tissue slice cultures for anticancer drug development

L He, C Deng - International journal of biological sciences, 2022 - ncbi.nlm.nih.gov
Organotypic tissue slice culture is established from animal or patient tissues and cultivated
in an in vitro ecosystem. This technique has made countless contributions to anticancer drug …

Review of meningioma diagnosis and management

C Hanna Jr, M Willman, D Cole, Y Mehkri, S Liu… - Egyptian journal of …, 2023 - Springer
Meningiomas are the most common intracranial tumors in adult patients. Although the
majority of meningiomas are diagnosed as benign, approximately 20% of cases are high …

A review of the role of stereotactic radiosurgery and immunotherapy in the management of primary central nervous system tumors

EJ Lehrer, BM Jones, KK Sindhu, DR Dickstein… - Biomedicines, 2022 - mdpi.com
Stereotactic radiosurgery (SRS) and immune checkpoint inhibitors (ICIs) are widely used in
the management of brain metastases. These therapies are commonly administered …

Mouse models in meningioma research: a systematic review

J Boetto, M Peyre, M Kalamarides - Cancers, 2021 - mdpi.com
Simple Summary Meningiomas are the most frequent primitive central nervous tumors in
adults. Mouse models of cancer are used to study disease mechanisms and to establish …

CDK 4/6 inhibitors for the treatment of meningioma

JS Young, RL Kidwell, A Zheng, AF Haddad… - Frontiers in …, 2022 - frontiersin.org
Meningiomas are the most common non-metastatic brain tumors, and although the majority
are relatively slow-growing and histologically benign, a subset of meningiomas are …

The effects of palbociclib in combination with radiation in preclinical models of aggressive meningioma

C Horbinski, G Xi, Y Wang, R Hashizume… - Neuro-oncology …, 2021 - academic.oup.com
Background Meningiomas are the most common tumor arising within the cranium of adults.
Despite surgical resection and radiotherapy, many meningiomas invade the brain, and …

Gemcitabine cooperates with everolimus to inhibit the growth of and sensitize malignant meningioma cells to apoptosis induced by navitoclax, an inhibitor of anti …

M Yamamoto, S Suzuki, K Togashi, A Sugai, M Okada… - Cancers, 2022 - mdpi.com
Simple Summary Meningioma is the most common intracranial neoplasm derived from the
arachnoid cap cells of the leptomeninges. Malignant meningioma is generally more …

Meningioma animal models: a systematic review and meta-analysis

MS Andersen, MS Kofoed, AS Paludan-Müller… - Journal of Translational …, 2023 - Springer
Background Animal models are widely used to study pathological processes and drug (side)
effects in a controlled environment. There is a wide variety of methods available for …